Skip to main content
. 2017 Dec 8;9(4):4661–4674. doi: 10.18632/oncotarget.23163

Table 2. Differentially expressed miRNAs between sunitinb-sensitive and resistant tumors*.

miRNA name in vitro (log2FC) in vivo (log2FC) adj.P.Val
hsa-miR-483-5p −8.5 −6.9 0.00000
hsa-miR-483-3p −3.2 −4.5 0.00000
hsa-miR-18a-3p −10.6 −2.3 0.00023
hsa-miR-618 −1.2 −1.7 0.03615
hsa-miR-486-3p −1.8 −1.6 0.01404
hsa-miR-1254 −1.1 −1.5 0.01257
hsa-miR-1247-5p −2.5 −1.4 0.01087
hsa-miR-875-5p −16.1 −1.4 0.03615
hsa-miR-939-5p −2.4 −1.4 0.03615
hsa-miR-7-1-3p −1.1 −1.4 0.00452
hsa-miR-454-5p −1.6 −1.2 0.00356
hsa-miR-1276 −8.9 −1.2 0.03128
hsa-miR-543 −3.7 −1.2 0.03615
hsa-miR-30e-3p −2.1 −1.2 0.00066
hsa-miR-30c-2-3p −2.8 −1.1 0.00042
hsa-miR-29c-5p 1.3 2.0 0.03128
hsa-miR-655-3p 9.8 2.2 0.00131
hsa-miR-145-5p 16.4 2.2 0.00011
hsa-miR-10b-5p 1.1 2.3 0.00001
hsa-miR-615-3p 1.6 2.7 0.00000
hsa-miR-9-5p 1.2 2.8 0.00218
hsa-miR-22-5p 1.5 3.0 0.00001
hsa-miR-15a-5p 4.7 3.2 0.00000
hsa-miR-758-3p 3.6 3.7 0.00001
hsa-miR-382-5p 5.3 4.0 0.00016
hsa-miR-183-3p 5.2 4.2 0.00002
hsa-miR-223-3p 8.7 4.2 0.00000
hsa-miR-335-3p 2.1 4.3 0.00000
hsa-miR-582-5p 8.4 4.5 0.00031
hsa-miR-154-5p 1.1 4.5 0.00000
hsa-miR-190a-5p 4.5 5.0 0.00000
hsa-miR-375 30.8 5.1 0.00000
hsa-miR-769-5p 12.1 7.0 0.00000
hsa-miR-889-3p 2.6 7.1 0.00000
hsa-miR-654-3p 5.8 7.5 0.00000
hsa-miR-92a-3p 12.4 9.2 0.00000